Francesco Pichi, MD, is a Clinical Associate in the Eye Institute at Cleveland Clinic Abu Dhabi, where he subspecializes in diseases of the retina, uveitis, ocular inflammations and infections.
Prior to joining Cleveland Clinic Abu Dhabi, Dr. Pichi worked at the Cole Eye Institute, at Cleveland Clinic in Ohio, US.
Dr. Pichi’s experience in both Europe and the US has contributed to his diverse expertise in disease presentations in the fields of retina and uveitis. His clinical and research work has contributed to innovations in the fields of retinal imaging and the treatment of inflammatory eye diseases. He was part of the European Study Group that discovered the application of mineralocorticoid receptors antagonists for the oral treatment of central serous chorioretinopathy. He was also a leader in employing a non-invasive new imaging modality such as Optical Coherence Tomography Angiography to assess the status of the iris vessels in patients with vascular diseases such as hypertension, diabetes and vasculitis.
Dr. Pichi’s current research interest is the use of multimodal imaging of the retina in order to understand the etiology of various pathologies and to accurately guide treatment. In the fields of uveitis and ocular inflammation, his efforts are in creating objective ways of measuring inflammation which would provide a better outcome for patients.
Dr. Pichi graduated summa cum laude from the Alma Mater Studiorum of the University of Bologna, Bologna, Italy and went on to pursue his ophthalmology residency at the University of Milan, Milan, Italy, where he trained in cataract surgery. During his training, he developed an interest in the fields of medical retina and uveitis, and became an intern at Moorfields Eye Hospital, London, UK.
He underwent a preceptorship in uveitis and ocular immunology at Bascom Palmer Eye Institute, University of Miami, US. He also pursued a two-year fellowship at the Cole Eye Institute, Cleveland Clinic, Ohio, US in uveitis, ocular inflammations and infections.